PHC Holdings KK

6523

Equity

ISIN JP3801300009 / Valor 113593974

Tokyo Stock Exchange (2024-11-21)

JPY 976.00+1.88%

PHC Holdings KK
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

PHC Holdings KK is a diversified global healthcare company engaged in various sectors including anatomical pathology, diabetes care, scientific research equipment, digital healthcare transformation, clinical testing, and in vitro diagnostics. The company operates through several subsidiaries, each specializing in distinct areas. Epredia Holdings Ltd. focuses on precision cancer diagnostics, offering instruments, microscope slides, consumables, and dyeing reagents. Ascensia Diabetes Care Holdings AG provides glucose monitoring systems and digital diabetes management solutions. PHCbi develops equipment for sample preservation, cell culture, and clean research environments. WEMEX drives digital healthcare transformation in Japan with electronic medical records, e-prescriptions, and telemedicine systems. LSI Medience Corporation offers clinical testing services aimed at illness prevention and early detection. Mediford supports drug research and development through advanced clinical and non-clinical testing. PHC IVD specializes in medical devices and in vitro diagnostics, with a history of pioneering developments in clinical diagnostic reagents and blood glucose sensors.

Summarized from source with an LLMView SourceSector: Technology

Revenue Growth

PHC Holdings KK reported a revenue of JPY 85,187 million for the first quarter of the fiscal year ending March 31, 2025, marking a 4.7% increase compared to the same period in the previous year. This growth was driven by stable performance in Diabetes Management and increased revenue in Healthcare Solutions due to M&A activities.

Operating Profit

For the first quarter of the fiscal year ending March 31, 2025, PHC Holdings KK achieved an operating profit of JPY 2,027 million, which represents an 18.4% increase year on year. The improvement was attributed to cost reductions and increased revenue in the Healthcare Solutions segment.

Loss Before Tax

PHC Holdings KK reported a loss before tax of JPY 2,762 million for the first quarter of the fiscal year ending March 31, 2025. This was an improvement from the JPY 3,588 million loss reported in the same period of the previous year, primarily due to increased operating profit and decreased interest expenses.

Profit Attributable to Owners

The loss attributable to owners of the parent for PHC Holdings KK in the first quarter of the fiscal year ending March 31, 2025, was JPY 3,173 million. This was a slight improvement from the JPY 3,200 million loss reported in the same period of the previous year.

Adjusted EBITDA

PHC Holdings KK's adjusted EBITDA for the first quarter of the fiscal year ending March 31, 2025, was JPY 9,522 million, reflecting a 5.0% decrease year on year. The decline was due to one-time income/expense adjustments related to restructuring and other factors.

Summarized from source with an LLMView Source

Key figures

-34.5%1Y

-61.7%3Y

%5Y

Performance

35.5%1Y

35.4%3Y

35.5%5Y

Volatility